NuCana Plc (NCNA)
1.37
-0.01
(-0.72%)
USD |
NASDAQ |
Sep 02, 14:19
NuCana Free Cash Flow : -6.612M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.612M |
| March 31, 2026 | -9.929M |
| December 31, 2025 | -9.668M |
| September 30, 2025 | -18.20M |
| June 30, 2025 | -25.56M |
| March 31, 2025 | -21.09M |
| December 31, 2024 | -24.57M |
| September 30, 2024 | -14.31M |
| June 30, 2024 | -21.43M |
| March 31, 2024 | -27.39M |
| December 31, 2023 | -32.35M |
| September 30, 2023 | -40.26M |
| June 30, 2023 | -24.82M |
| March 31, 2023 | -28.77M |
| December 31, 2022 | -28.15M |
| September 30, 2022 | -34.91M |
| Date | Value |
|---|---|
| June 30, 2022 | -38.75M |
| March 31, 2022 | -34.49M |
| December 31, 2021 | -34.05M |
| September 30, 2021 | -31.87M |
| June 30, 2021 | -37.51M |
| March 31, 2021 | -32.47M |
| December 31, 2020 | -29.39M |
| September 30, 2020 | -21.89M |
| June 30, 2020 | -25.26M |
| March 31, 2020 | -30.60M |
| December 31, 2019 | -30.30M |
| September 30, 2019 | -29.09M |
| June 30, 2019 | -23.85M |
| March 31, 2019 | -21.21M |
| December 31, 2018 | -17.28M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -8.310M |
| Mereo BioPharma Group Plc | -25.58M |
| BioNTech SE | 424.34M |
| Silence Therapeutics Plc | -41.79M |
| Autolus Therapeutics Plc | -240.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.571M |
| Cash from Investing (Quarterly) | -0.0453M |
| Cash from Financing (Quarterly) | 0.0685M |
| Free Cash Flow Per Share (Quarterly) | -0.625 |
| Free Cash Flow to Equity (Quarterly) | -2.611M |
| Free Cash Flow to Firm (Quarterly) | -2.616M |
| Free Cash Flow Yield | -119.1% |